Подписаться
Samuli Eldfors, PhD
Samuli Eldfors, PhD
Research Scientist, MEE, Harvard Medical School
Подтвержден адрес электронной почты в домене mgh.harvard.edu
Название
Процитировано
Процитировано
Год
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
HLM Koskela, S Eldfors, P Ellonen, AJ van Adrichem, H Kuusanmäki, ...
New England Journal of Medicine 366 (20), 1905-1913, 2012
8982012
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid LeukemiaISM Approach to Therapy Selection
T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors, A Szwajda, ...
Cancer discovery 3 (12), 1416-1429, 2013
472*2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
HLM Rajala, S Eldfors, H Kuusanmäki, AJ Van Adrichem, T Olson, ...
Blood, The Journal of the American Society of Hematology 121 (22), 4541-4550, 2013
3422013
Comparison of solution-based exome capture methods for next generation sequencing
AM Sulonen, P Ellonen, H Almusa, M Lepistö, S Eldfors, S Hannula, ...
Genome biology 12, 1-18, 2011
3412011
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3
EM Haapaniemi, M Kaustio, HLM Rajala, AJ van Adrichem, L Kainulainen, ...
Blood, The Journal of the American Society of Hematology 125 (4), 639-648, 2015
3032015
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
O Dufva, M Kankainen, T Kelkka, N Sekiguchi, SA Awad, S Eldfors, ...
Nature communications 9 (1), 1567, 2018
1382018
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, EI Andersson, ...
Leukemia 28 (8), 1738-1742, 2014
1342014
Implementing a functional precision medicine tumor board for acute myeloid leukemia
D Malani, A Kumar, O Brück, M Kontro, B Yadav, M Hellesøy, ...
Cancer Discovery 12 (2), 388-401, 2022
1282022
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis
P Savola, T Kelkka, HL Rajala, A Kuuliala, K Kuuliala, S Eldfors, ...
Nature communications 8 (1), 15869, 2017
1172017
High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia
EI Andersson, T Tanahashi, N Sekiguchi, VR Gasparini, S Bortoluzzi, ...
Blood, The Journal of the American Society of Hematology 128 (20), 2465-2468, 2016
1132016
Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer
K Saeed, V Rahkama, S Eldfors, D Bychkov, JP Mpindi, B Yadav, ...
European urology 71 (3), 319-327, 2017
1002017
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
M Kontro, A Kumar, MM Majumder, S Eldfors, A Parsons, T Pemovska, ...
Leukemia 31 (2), 301-309, 2017
1002017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
EI Andersson, S Pützer, B Yadav, O Dufva, S Khan, L He, L Sellner, ...
Leukemia 32 (3), 774-787, 2018
972018
Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia
E Andersson, H Kuusanmäki, S Bortoluzzi, S Lagström, A Parsons, ...
Leukemia 30 (5), 1204-1208, 2016
942016
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
EI Andersson, HLM Rajala, S Eldfors, P Ellonen, T Olson, A Jerez, ...
Blood cancer journal 3 (12), e168-e168, 2013
842013
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
H Kuusanmäki, O Dufva, M Vähä-Koskela, AM Leppä, J Huuhtanen, ...
Blood 141 (13), 1610-1625, 2023
632023
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
JL Kivioja, A Thanasopoulou, A Kumar, M Kontro, B Yadav, MM Majumder, ...
Leukemia 33 (6), 1360-1372, 2019
602019
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia
S Adnan Awad, M Kankainen, T Ojala, P Koskenvesa, S Eldfors, ...
Blood advances 4 (3), 546-559, 2020
582020
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
S Eldfors, H Kuusanmäki, M Kontro, MM Majumder, A Parsons, H Edgren, ...
Leukemia 31 (1), 51-57, 2017
582017
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML
D Malani, A Murumägi, B Yadav, M Kontro, S Eldfors, A Kumar, ...
Leukemia 31 (5), 1187-1195, 2017
572017
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20